gastric cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Gastric adenocarcinoma diagnosed by biopsy Un resectable cancer Gastric cancer which does not occur in residual stomach after surgery Patients who are not be able to take solid meal due to a stricture caused by tumor Patients who are assessed to be able to have the operations Blood test which is taken within 2 weeks before registration show following results; White blood cell count >3000/mm3 Hemoglobin level >7.0 g/dL Platelet count>100,000 /mm3 Serum total bilirubin level<3.0 mg/dL Serum creatinine level <2.0 mg/dL Performance status score 0-2 Patents with survival expectancy more than 3 months The enrollment in the study is confirmed in written consent
Exclusion criteria
Exclusion criteria: Cases of emergency operation for gastric perforation,bleeding or etc. Cases of simultaneous or recurrence of heterochronous active double cancer Patients with a history of or are suspected of brain metastasis or carcinomatous meningitis Patients with Disseminated Intravascular Coagulation Patients with mental disorder or abnormal mental status and are assessed to be difficult to join the study Patients with severe ascites Patients with a history of radiotherapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Length of the period which oral intake is possible after the intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety of the procedure, Improvement of oral intake, Survival period after the procedure, Necessity of additional intervention, Length of the period which patient is able to stay home, Quality of life after the procedure | — |
Countries
Japan
Contacts
Osaka University Gastroenterological Sugery